Basit öğe kaydını göster

dc.contributor.authorAydın, Esra
dc.contributor.authorÜRÜN, YÜKSEL
dc.contributor.authorÇİÇİN, İRFAN
dc.contributor.authorSaip, Pinar
dc.contributor.authorDogan, Izzet
dc.contributor.authorAyhan, Murat
dc.contributor.authorGurbuz, Mustafa
dc.contributor.authorKucukarda, Ahmet
dc.date.accessioned2023-02-21T07:30:48Z
dc.date.available2023-02-21T07:30:48Z
dc.date.issued2022
dc.identifier.citationDogan I., Ayhan M., Gurbuz M., Kucukarda A., Aydın E., ÜRÜN Y., ÇİÇİN İ., Saip P., "The frequency and prognostic significance of ABO/Rh blood groups in male breast cancer patients: A multicenter study", MEDICINE, cilt.101, sa.35, 2022
dc.identifier.issn0025-7974
dc.identifier.othervv_1032021
dc.identifier.otherav_078d666e-154c-4d31-b907-3b4df8e88195
dc.identifier.urihttp://hdl.handle.net/20.500.12627/185864
dc.identifier.urihttps://doi.org/10.1097/md.0000000000030147
dc.description.abstractThe study evaluated the distributions and prognostic significance of ABO and rhesus (D) groups in male breast cancer (MBC) patients. The data of 137 patients were retrospectively reviewed. Clinical, histopathological data and ABO/Rh blood groups of the patients were recorded. The ABO/Rh blood group distributions were compared to the healthy men control group (n = 120,160) by the chi-square test. Overall distributions of ABO blood groups were different between the patients (17.5% AB, 38% A, 19% B, and 25.5% O) and control group (7.88% AB, 42.06% A, 15.22% B, and 34.84% O) (P < .001). There were significant differences between the patients and control group with respect to AB vs non-AB blood group distributions (P < .001, odds ratio: 2.43, 95% CI) and O vs non-O blood group distributions (P = .016, odds ratio: 0.62, 95% CI). However, A vs non-A and B vs non-B blood group distributions were not significantly different. The distribution of the Rh factor was similar between patients and the control group (P = .93). In univariate analysis, ABO/Rh blood groups were not a prognostic factor on OS (P = .29). The frequency of the AB blood group in MBC patients is increased than in the healthy control group. AB blood group may be a risk factor for MBC, whereas O blood group may be a protective factor.
dc.language.isoeng
dc.subjectGenel Tıp
dc.subjectTIP, GENEL & DAHİLİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectTemel Tıp Bilimleri
dc.subjectGenel Sağlık Meslekleri
dc.subjectPatofizyoloji
dc.subjectTemel Bilgi ve Beceriler
dc.subjectDeğerlendirme ve Teşhis
dc.subjectDahiliye
dc.subjectAile Sağlığı
dc.subjectTıp (çeşitli)
dc.titleThe frequency and prognostic significance of ABO/Rh blood groups in male breast cancer patients: A multicenter study
dc.typeMakale
dc.relation.journalMEDICINE
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume101
dc.identifier.issue35
dc.contributor.firstauthorID3455191


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster